☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR (State or other jurisdiction of incorporation or organization) 11455 El Camino Real, San Diego, CA 92130 (Address of principal executive offices) (Zip Code) (858) 369-71 ...

On Target: Developing Best-in-Class Cancer Therapies H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 Forward-Looking Statements This presentation contains, and our officers and representatives may from time to time make, statements that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Examples of forward-looking statements include, among others, statements regarding our development s ...

On Target: Developing Best-in-Class Cancer Therapies 2021 Wells Fargo Virtual Healthcare Conference September 9, 2021 Forward-Looking Statements This presentation contains, and our officers and representatives may from time to time make, statements that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Examples of forward-looking statements include, among others, statements regarding our development strategy; poten ...

MEI Pharma, Inc. (NASDAQ:MEIP) Q4 2021 Earnings Conference Call September 2, 2021 5:00 PM ET Company Participants David Walsey - Vice President, Investor Relations and Corporate Communications Brian Drazba - Chief Financial Officer Dan Gold - President and Chief Executive Officer Conference Call Participants Bonnie Quach - Stifel Financial Corp Yale Jen - Laidlaw & Company Srikripa Devarakonda - Truist Securities Adam Evertts - LifeSci Capital Matthew Cross - Alliance Global Partners Operator Good afternoon ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-50484 MEI Pharma, Inc. (Exact name of registrant as specified in its charter) DELAWARE 51-0407811 (State or other jurisdiction ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR (Exact name of registrant as specified in its charter) DELAWARE 51-0407811 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 11455 El Camino Real, San Diego, CA 92130 (Address of principal executive offices) (Zip Code) (858 ...

Building a Leading Oncology Franchise April 13, 2021 NASDAQ: MEIP Forward-Looking Statements • This presentation contains, and our officers and representatives may from time to time make, statements that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Examples of forward-looking statements include, among others, statements regarding our development strategy; potential advantages of our product candidates; the ini ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 OR (I.R.S. Employer Identification No.) 11455 El Camino Real, San Diego, CA 92130 (Address of principal executive offices) (Zip Code) (858) 369-7100 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: | | Trading ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-50484 MEI Pharma, Inc. (I.R.S. Employer Identification No.) 11455 El Camino Real, San Diego, CA 92130 (Address of pr ...

H.C. Wainwright 22nd Annual Global Investment Conference September 14, 2020 NASDAQ: MEIP Forward-Looking Statements • This presentation contains, and our officers and representatives may from time to time make, statements that are "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Examples of forward-looking statements include, among others, statements regarding our development strategy; potential advantages of our prod ...